{'52WeekChange': -0.30854434,
 'SandP52WeekChange': 0.0644362,
 'address1': '99 Erie Street',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 8.82,
 'askSize': 900,
 'averageDailyVolume10Day': 111400,
 'averageVolume': 63119,
 'averageVolume10days': 111400,
 'beta': None,
 'beta3Year': None,
 'bid': 8.5,
 'bidSize': 1300,
 'bookValue': 1.452,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cambridge',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 9.1,
 'dayLow': 8.74,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -4.08,
 'enterpriseToRevenue': 167.484,
 'enterpriseValue': 171000960,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 8.072286,
 'fiftyTwoWeekHigh': 14,
 'fiftyTwoWeekLow': 3.05,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 8379721,
 'forwardEps': -1.81,
 'forwardPE': -4.828729,
 'fromCurrency': None,
 'fullTimeEmployees': 41,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.21139,
 'heldPercentInstitutions': 0.68232,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/logicbio.com',
 'longBusinessSummary': 'LogicBio Therapeutics, Inc., a genome editing '
                        'company, focuses on developing medicines to treat '
                        'rare diseases in patients with unmet medical need '
                        'using GeneRide technology platform. The GeneRide '
                        'technology is designed to integrate corrective genes '
                        "into a patient's genome to provide a therapeutic "
                        'effect. Its lead product candidate is LB-001 for the '
                        'treatment of Methylmalonic Acidemia, a '
                        'life-threatening disease that presents at birth. The '
                        "company has a partnership with Children's Medical "
                        'Research Institute to develop new viral vectors; and '
                        'a collaboration agreement with Takeda Pharmaceutical '
                        'Company Limited to develop new genome editing '
                        'candidate Lb-301 for the treatment of crigler-najjar '
                        'syndrome. LogicBio Therapeutics, Inc. was founded in '
                        '2014 and is headquartered in Cambridge, '
                        'Massachusetts.',
 'longName': 'LogicBio Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 204809664,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_322758292',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -41886000,
 'nextFiscalYearEnd': 1640908800,
 'open': 8.78,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '617-245-0399',
 'previousClose': 8.87,
 'priceHint': 2,
 'priceToBook': 6.0192833,
 'priceToSalesTrailing12Months': 200.59712,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 9.1,
 'regularMarketDayLow': 8.74,
 'regularMarketOpen': 8.78,
 'regularMarketPreviousClose': 8.87,
 'regularMarketPrice': 8.78,
 'regularMarketVolume': 46597,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 23433600,
 'sharesPercentSharesOut': 0.0075,
 'sharesShort': 175226,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 66095,
 'shortName': 'LogicBio Therapeutics, Inc.',
 'shortPercentOfFloat': 0.0138,
 'shortRatio': 2.6,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'LOGC',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.836,
 'twoHundredDayAverage': 7.2956114,
 'volume': 46597,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.logicbio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02139'}